104 related articles for article (PubMed ID: 18197819)
1. Rapid clearance of bacteria and their toxins: development of therapeutic proteins.
Kunkel M; Vuyisich M; Gnanakaran G; Bruening GE; Dandekar AM; Civerolo E; Marchalonis JJ; Gupta G
Crit Rev Immunol; 2007; 27(3):233-45. PubMed ID: 18197819
[TBL] [Abstract][Full Text] [Related]
2. Cyclodextrin derivatives as anti-infectives.
Karginov VA
Curr Opin Pharmacol; 2013 Oct; 13(5):717-25. PubMed ID: 24011515
[TBL] [Abstract][Full Text] [Related]
3. Type-IIA secreted phospholipase A2 is an endogenous antibiotic-like protein of the host.
Wu Y; Raymond B; Goossens PL; Njamkepo E; Guiso N; Paya M; Touqui L
Biochimie; 2010 Jun; 92(6):583-7. PubMed ID: 20144678
[TBL] [Abstract][Full Text] [Related]
4. The designer proline-rich antibacterial peptide A3-APO prevents Bacillus anthracis mortality by deactivating bacterial toxins.
Otvos L; Flick-Smith H; Fox M; Ostorhazi E; Dawson RM; Wade JD
Protein Pept Lett; 2014 Apr; 21(4):374-81. PubMed ID: 24164262
[TBL] [Abstract][Full Text] [Related]
5. Production of an engineered killer peptide in Nicotiana benthamiana by using a potato virus X expression system.
Donini M; Lico C; Baschieri S; Conti S; Magliani W; Polonelli L; Benvenuto E
Appl Environ Microbiol; 2005 Oct; 71(10):6360-7. PubMed ID: 16204558
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of an inter-generic bivalent alpha domain fusion protein αCS from Clostridium perfringens and Staphylococcus aureus for concurrent diagnosis and therapeutic applications.
Uppalapati SR; Kingston JJ; Murali HS; Batra HV
J Appl Microbiol; 2012 Aug; 113(2):448-58. PubMed ID: 22563989
[TBL] [Abstract][Full Text] [Related]
7. Toxin-Antitoxin Systems in Clinical Pathogens.
Fernández-García L; Blasco L; Lopez M; Bou G; García-Contreras R; Wood T; Tomas M
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27447671
[TBL] [Abstract][Full Text] [Related]
8. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
Uppalapati SR; Kingston JJ; Murali HS; Batra HV
Vaccine; 2014 May; 32(25):3075-81. PubMed ID: 24699467
[TBL] [Abstract][Full Text] [Related]
9. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activities and action mechanism studies of transportan 10 and its analogues against multidrug-resistant bacteria.
Xie J; Gou Y; Zhao Q; Li S; Zhang W; Song J; Mou L; Li J; Wang K; Zhang B; Yang W; Wang R
J Pept Sci; 2015 Jul; 21(7):599-607. PubMed ID: 25891396
[TBL] [Abstract][Full Text] [Related]
11. Design, recombinant expression, and antibacterial activity of a novel hybrid magainin-thanatin antimicrobial peptide.
Tian L; Zhang D; Su P; Wei Y; Wang Z; Wang PX; Dai CJ; Gong GL
Prep Biochem Biotechnol; 2019; 49(5):427-434. PubMed ID: 30861356
[TBL] [Abstract][Full Text] [Related]
12. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.
Li Q; Montalban-Lopez M; Kuipers OP
Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984
[TBL] [Abstract][Full Text] [Related]
13. Comparative Analysis of the Antimicrobial Activities of Plant Defensin-Like and Ultrashort Peptides against Food-Spoiling Bacteria.
Kraszewska J; Beckett MC; James TC; Bond U
Appl Environ Microbiol; 2016 Jul; 82(14):4288-4298. PubMed ID: 27208129
[TBL] [Abstract][Full Text] [Related]
14. Combating infectious diseases through multivalent design.
Fan E; Merritt EA
Curr Drug Targets Infect Disord; 2002 Jun; 2(2):161-7. PubMed ID: 12462146
[TBL] [Abstract][Full Text] [Related]
15. Dual effect of synthetic aminoglycosides: antibacterial activity against Bacillus anthracis and inhibition of anthrax lethal factor.
Fridman M; Belakhov V; Lee LV; Liang FS; Wong CH; Baasov T
Angew Chem Int Ed Engl; 2005 Jan; 44(3):447-52. PubMed ID: 15624157
[No Abstract] [Full Text] [Related]
16. The effects of macrolides on the expression of bacterial virulence mechanisms.
Shryock TR; Mortensen JE; Baumholtz M
J Antimicrob Chemother; 1998 May; 41(5):505-12. PubMed ID: 9630404
[TBL] [Abstract][Full Text] [Related]
17. In silico Analysis of Toxins of Staphylococcus aureus for Validating Putative Drug Targets.
Mohana R; Venugopal S
Infect Disord Drug Targets; 2017; 17(2):130-142. PubMed ID: 28034364
[TBL] [Abstract][Full Text] [Related]
18. High-yield recombinant expression of the chicken antimicrobial peptide fowlicidin-2 in Escherichia coli.
Feng X; Xu W; Qu P; Li X; Xing L; Liu D; Jiao J; Wang J; Li Z; Liu C
Biotechnol Prog; 2015; 31(2):369-74. PubMed ID: 25641948
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs.
Supuran CT
Curr Med Chem; 2012; 19(6):831-44. PubMed ID: 22214451
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of the fruits of Iranian Torilis leptophylla against some clinical pathogens.
Maleki S; Seyyednejad SM; Damabi NM; Motamedi H
Pak J Biol Sci; 2008 May; 11(9):1286-9. PubMed ID: 18819541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
